Data as of Apr 15
| 0.00 / 0.00%|
The 12 analysts offering 12-month price forecasts for Mindray Medical International Ltd have a median target of 37.40, with a high estimate of 46.00 and a low estimate of 27.00. The median estimate represents a +13.33% increase from the last price of 33.00.
The current consensus among 12 polled investment analysts is to Hold stock in Mindray Medical International Ltd. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.